Cas:10602-04-7 (4-Ethynylphenyl)methanol manufacturer & supplier

We serve Chemical Name:(4-Ethynylphenyl)methanol CAS:10602-04-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(4-Ethynylphenyl)methanol

Chemical Name:(4-Ethynylphenyl)methanol
CAS.NO:10602-04-7
Synonyms:Benzenemethanol, 4-ethynyl-;(4-ethylynphenyl)methanol;Benzylalcohol,p-ethynyl-(7CI,8CI);(p-ethynylphenyl)methanol;(4-Ethynylphenyl)methanol;1-Ethynyl-4-(hydroxymethyl)benzene;4-Ethynyl-benzenemethanol;4-hydroxymethylphenylacetylene;4-Ethynylbenzyl alcohol;Benzenemethanol,4-ethynyl
Molecular Formula:C9H8O
Molecular Weight:132.159
HS Code:2906299090

Physical and Chemical Properties:
Melting point:40-44ºC(lit.)
Boiling point:239.6±23.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.573
PSA:20.23000
Exact Mass:132.057510
LogP:1.22

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzenemethanol, 4-ethynyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenemethanol,4-ethynyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-hydroxymethylphenylacetylene Use and application,(4-ethylynphenyl)methanol technical grade,usp/ep/jp grade.


Related News: The Global Talent Visa, along with the High Potential Individual and Scale-up visa routes in the Innovation Strategy, provide fast-track visa routes for high skills individuals and their teams, attracting top research talent to the UK. sulfanylidenemethanone manufacturers Rodent preclinical studies showed that MSP-1014 displayed superior in vivo and safety profiles in mice compared to psilocybin at a range of doses, and 5-HT2A subtype activation in rats. 4-cyano-4′-ethoxybiphenyl suppliers Plexxikon filed a lawsuit against the pharma giant in 2017, alledging that Tafinlar, a rival to its melanoma drug Zelboraf that was brought to market in collaboration with Roche, has stepped on its intellectual property. The jury ruled in its favor, adding that the infringement is in fact willful. 2-(dibenzylamino)-4-methylpentan-1-ol vendor & factory.